# A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood

> **NCT03794323** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 764122
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03794323
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-30
- **Primary completion:** 2019-08-12
- **Final completion:** 2019-08-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03794323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03794323, "A Study in Healthy Men to Find Out How Well Different Doses of BI 764122 Are Tolerated and Whether Food Affects the Amount of BI 764122 in the Blood". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03794323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*